{"product_id":"mayo-clinic-cardiovascular-online-board-review-2023","title":"Mayo Clinic Cardiovascular Online Board Review 2023 (Videos+Slides PDF)","description":"\u003ch2\u003eMayo Clinic Cardiovascular Online Board Review 2023\u003c\/h2\u003e\u003cbr\u003eMayo Clinic Cardiovascular Online Board Review \u003cspan lang=\"EN\"\u003eprovides the internist and cardiologist with an overview of all aspects of cardiovascular medicine. Well-known experts in each field will give in-depth didactic presentations on state-of-the-art subjects in cardiovascular medicine. This review course is designed specifically to prepare the cardiovascular specialist for the cardiovascular boards and\/or recertification.\u003c\/span\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cspan lang=\"EN\"\u003e This course will also provide the internist or practicing cardiologist with an update on the latest knowledge and advances in cardiovascular medicine.  The Echo Focus Session is part of the enduring program as well. \u003cb\u003ePlease Note:\u003c\/b\u003e The Echo Focus portion is “bonus” material and not intended for use for studying for the boards.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan lang=\"EN\"\u003eThe Cardiovascular Online Board Review course is delivered through an online personalized learning gateway enabling learners to take a pre-assessment to identify areas of strength and weakness and then directing their learning with a personalized study guide that concentrates solely on areas where they need reinforcement. Learners can view videos from the live\/livestream course, listen to streaming audio presentations, review learning objectives, journal citations, articles and guidelines and board pearls, take notes on PowerPoint presentations, take pre- and post-assessments, practice coding exams, and more.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003c\/h2\u003e\n\u003ch2\u003e\n\u003cstrong\u003eDate of Original Release\u003c\/strong\u003e: December 12, 2023\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eCourse Learning Objectives\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cspan lang=\"EN\"\u003eBelow is a sampling of the \u003c\/span\u003e\u003cspan lang=\"EN\"\u003eCardiovascular Board Review for Initial Certification and Recertification\u003c\/span\u003e\u003cspan lang=\"EN\"\u003e course objectives.  Upon conclusion of this program, participants should be able to:\u003c\/span\u003e\n\u003cbr\u003e\u003ch5\u003eDescribe the etiology and pathophysiology of restrictive and other non-dilated cardiomyopathies and use this information to effectively diagnose and manage patients.\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eVALVULAR DISEASE:\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eIdentify venous thromboembolism (VTE), incorporating the pre-test probability of VTE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003eDiagnose venous thromboembolism (VTE), incorporating the pre-test probability of VTE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003eSelect appropriate management of venous thromboembolism (VTE), incorporating the pre-test probability of VTE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVALVULAR DISEASE:\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eIdentify pulmonary embolism (PE), incorporating the pre-test probability of PE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003eDiagnose pulmonary embolism (PE), incorporating the pre-test probability of PE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003eSelect appropriate management of pulmonary embolism (PE), incorporating the pre-test probability of PE based on clinical presentation and initial diagnostic testing.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCAD:\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eIdentify cardiovascular disease risk factors in patients without known CAD.\u003c\/li\u003e\n\u003cli\u003eDetermine the risk of future coronary events in patients without known CAD.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eARRYTHMIAS:\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eClassify antiarrhythmic agents according to mechanisms of action.\u003c\/li\u003e\n\u003cli\u003eChoose appropriate antiarrhythmic agents for specific patients with cardiovascular arrhythmias.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCONGENITAL:\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eSpecify the physiologic changes that occur with pregnancy.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eEcho Focus Session Learning Objectives\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003eUtilize Echo and Doppler information for management of patients with various cardiovascular\u003cbr\u003econditions.\u003c\/li\u003e\n\u003cli\u003eIdentify new echocardiographic modalities for clinical use such as tissue Doppler and strain imaging.\u003c\/li\u003e\n\u003cli\u003eRecognize common and unusual cardiovascular conditions confidently by echocardiography.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThis enduring program is designed for, but not limited to, cardiologists, cardiovascular fellows, and general internists. Although this program is designed specifically to prepare the cardiovascular specialist for the cardiovascular boards and\/or recertification, it will also provide the practicing cardiologist or internist with an update on the latest knowledge and advances in cardiovascular medicine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003e\u003cstrong\u003esampples\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/485\" style=\"color: #3366ff;\"\u003ehttps:\/\/t.me\/medicalamboss1\/485  \u003c\/a\u003e\u003c\/span\u003e\n\u003cbr\u003e\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/486\" style=\"color: #3366ff;\"\u003ehttps:\/\/t.me\/medicalamboss1\/486\u003c\/a\u003e\u003c\/span\u003e\n\u003cbr\u003e\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/483\" style=\"color: #3366ff;\"\u003ehttps:\/\/t.me\/medicalamboss1\/483\u003c\/a\u003e\u003c\/span\u003e\n\u003cbr\u003e\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/487\" style=\"color: #3366ff;\"\u003ehttps:\/\/t.me\/medicalamboss1\/487\u003c\/a\u003e\u003c\/span\u003e\n\u003cbr\u003e\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/483\" style=\"color: #3366ff;\"\u003ehttps:\/\/t.me\/medicalamboss1\/483\u003c\/a\u003e\u003c\/span\u003e\n\u003cbr\u003e\u003ch2 class=\"page-title\"\u003eContent\u003c\/h2\u003e\n\u003cdiv class=\"styled-content-holder\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eArrhythmias\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eAtrial Fibrillation and SVT: Diagnosis and Stroke Prevention\u003cbr\u003eAmmar M. Killu, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation and SVT: Treatment\u003cbr\u003eMalini Madhavan, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003eVentricular Arrhythmias\u003cbr\u003eSiva K. Mulpuru, M.D.\u003c\/li\u003e\n\u003cli\u003eThe Cardiac Channelopathies (Brugada, CPVT, and LQTS)\u003cbr\u003eMichael J. Ackerman, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eAntiarrhythmic Drugs, Interactions, and Proarrhythmias\u003cbr\u003eKonstantinos Siontis, M.D.\u003c\/li\u003e\n\u003cli\u003eSyncope and Out-of-Hospital Arrest: Non-Invasive and Invasive Testing and Treatments\u003cbr\u003eAbhishek J. Deshmukh, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003ePacemakers, ICDs, and Cardiac Resynchronization Therapy\u003cbr\u003eAmmar M. Killu, M.B.B.S.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eNormal Cardiovascular Anatomy and Physiology\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003ePregnancy and the Heart\u003cbr\u003eKathleen A. Young, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\n\u003cstrong\u003eCoronary Artery\u003c\/strong\u003e \u003cstrong\u003eDisease\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eAssessment and Primary Prevention of Patients at Risk for Cornary Artery Disease\u003cbr\u003eStephen L. Kopecky, M.D.\u003c\/li\u003e\n\u003cli\u003eAssessment and Medical Management of Paients with Known Coronary Artery Disease\u003cbr\u003ePanithaya Chareonthaitawee, M.D.\u003c\/li\u003e\n\u003cli\u003eEvaluation and Management of the Patient with Cardiac Disease for Non-Cardiac Surgery\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eACS Part I ‐ Presentation to Reperfusion\u003cbr\u003eGregory W. Barsness, M.D.\u003c\/li\u003e\n\u003cli\u003eACS Part II ‐ Adjunctive Medical Therapy\u003cbr\u003eS. Michael Gharacholou, M.D., M.S.\u003c\/li\u003e\n\u003cli\u003eComplications of Myocardial Infarction\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eMultimodality Imaging\u003cbr\u003ePanithaya Chareonthaitawee, M.D, Christopher François, M.D., Kathleen A. Young, M.D.\u003c\/li\u003e\n\u003cli\u003eRevascularization for Patients with Chronic Cornary Artery Disease\u003cbr\u003eAbhiram Prasad, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003e\u003cstrong\u003eCongenital Heart Disease\u003c\/strong\u003e\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eCongenital Heart Disease: Part 1 – Simple\u003cbr\u003eC. Charles Jain, M.D.\u003c\/li\u003e\n\u003cli\u003eCongenital Heart Disease: Part 2 – Complex\u003cbr\u003eSabrina D. Phillips, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003e\u003cstrong\u003eCoding for the Boards\u003c\/strong\u003e\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eECG Coding\u003cbr\u003eAbhishek J. Deshmukh, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003eCath Coding\u003cbr\u003eMackram F. Eleid, M.D.\u003c\/li\u003e\n\u003cli\u003eEcho Coding\u003cbr\u003eRekha Mankad, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eHeart Failure and Cardiomyopathy\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eThe Cardiomyopathies (CHF)\u003cbr\u003eSteve R. Ommen, M.D.\u003c\/li\u003e\n\u003cli\u003eVentricular Function\u003cbr\u003eMichael W. Cullen, M.D. \u0026amp; Jeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eMedical Treatment of Chronic Stable Heart Failure with Reduced Ejection Fraction\u003cbr\u003ePaul M. McKie, M.D.\u003c\/li\u003e\n\u003cli\u003eEvaluation and Management of HFpEF\u003cbr\u003eBarry A. Borlaug, M.D.\u003c\/li\u003e\n\u003cli\u003eMedical Treatment of Acute Decompensated Congestive Heart Failure\u003cbr\u003eAtta Behfar, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eCardiac Device and Replacement Therapy (Transplant)\u003cbr\u003eMelissa A. Lyle, M.D.\u003c\/li\u003e\n\u003cli\u003eConstriction vs. Restriction Hemodynamics\u003cbr\u003eS. Allen Luis, M.B.B.S., Ph.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003e\u003cstrong\u003ePulmonary Circulation Disorders\u003c\/strong\u003e\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003ePulmonary Hypertension\u003cbr\u003eSudhir Kushwaha, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003e\u003cstrong\u003eSystemic Hypertension and Hypotension\u003c\/strong\u003e\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eHypertension Basics\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003e\u003cstrong\u003eValvular Disease\u003c\/strong\u003e\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eInfective Endocarditis\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eValvular Stenosis\u003cbr\u003eVuyisile T. Nkomo, M.D., M.P.H.\u003c\/li\u003e\n\u003cli\u003eValvular Regurgitation\u003cbr\u003eSunil V. Mankad, M.D.\u003c\/li\u003e\n\u003cli\u003eProsthetic Valves and Other Forms of Valve Disease\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eHemodynamics\u003cbr\u003eMackram F. Eleid, M.D., Sunil V. Mankad, M.D., Michael W. Cullen, M.D. –  Moderator\u003c\/li\u003e\n\u003cli\u003eMitral and Aortic Regurgitation\u003cbr\u003eHector I. Michelena, M.D.\u003c\/li\u003e\n\u003cli\u003eMitral and Aortic Stenosis\u003cbr\u003eVuyisile T. Nkomo, M.D., M.P.H.\u003c\/li\u003e\n\u003cli\u003eTricuspid Valve Regurgitation\u003cbr\u003eRatnasari Padang, M.B.B.S., Ph.D.\u003c\/li\u003e\n\u003cli\u003eProsthetic Valves\u003cbr\u003eSorin V. Pislaru, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eEcho in the Diagnosis and Evaluation of Endocarditis\u003cbr\u003eRatnasari Padang, M.B.B.S., Ph.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003ePericardial Disease\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003ePericardial Disease and Myocarditis\u003cbr\u003eS. Allen Luis, M.B.B.S., Ph.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eVascular Diseases\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eDiseases of the Peripheral Arteries\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003cli\u003eDiseases of the Aorta and Great Vessels\u003cbr\u003eJohn P. Bois, M.D.\u003c\/li\u003e\n\u003cli\u003eThromboembolic and Other Venous Diseases\u003cbr\u003eRobert D. McBane, II, M.D.\u003c\/li\u003e\n\u003cli\u003eCarotid and Renal Vascular Disease\u003cbr\u003eIan R. McPhail, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eEchocardiography\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eClassic M-Mode and LV Systolic Function\u003cbr\u003eSunil V. Mankad, M.D.\u003c\/li\u003e\n\u003cli\u003eStress Echo: Role, Risk Wall Motion Analysis and Appropriateness\u003cbr\u003eAdelaide M. Arruda-Olson, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eRole of Echo in the CCU- Mechanical Complications of MI and Mimics of Myocardial Infarction\u003cbr\u003eSunil V. Mankad, M.D.\u003c\/li\u003e\n\u003cli\u003eEcho Assessment of Hypertrophic Cardiomyopathy\u003cbr\u003eKyle W. Klarich, M.D.\u003c\/li\u003e\n\u003cli\u003eEcho Assessment of Dilated Cardiomyopathy\u003cbr\u003eDaniel D. Borgeson, M.D.\u003c\/li\u003e\n\u003cli\u003eLV Diastolic Function\u003cbr\u003eJae K. Oh, M.D.\u003c\/li\u003e\n\u003cli\u003eRV Function and Pulmonary Hypertension\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eSimple Congenital Heart Disease\u003cbr\u003eWilliam R. Miranda, M.D.\u003c\/li\u003e\n\u003cli\u003eRecognizing Masses in the Heart and Source of Embolism\u003cbr\u003eKyle W. Klarich, M.D.\u003c\/li\u003e\n\u003cli\u003eInterventional Echocardiography: How 3D Helps in Daily Practice\u003cbr\u003eJeremy J. Thaden, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e*************************************************************************************************************\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eChalk Talks\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eChalk Talk 1\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 2\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 3\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 4\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 5\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 6\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 7\u003cbr\u003eSteve R. Ommen, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 8\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eChalk Talk 9\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003e\u003cstrong\u003eBonus Content\u003c\/strong\u003e\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eMolecular Genetics: Genetics 101-Understanding the Action Potential in the Human Heart\u003cbr\u003eMichael J. Ackerman, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eCardiac Amyloidosis for the Boards\u003cbr\u003eMartha Grogan, M.D.\u003c\/li\u003e\n\u003cli\u003eCardio-Oncology for the Boards: What the Cardiologist Needs to Know\u003cbr\u003eJoerg Herrmann, M.D.\u003c\/li\u003e\n\u003cli\u003eBasic Principles of Cardiovascular Pharmacology: Q\u0026amp;A\u003cbr\u003eGarvan C. Kane, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eBasic Principles of Cardiovascular Pharmacology: Cardiotixicity, Herbal Supplements, and Pharmacogenomics\u003cbr\u003eGarvan C. Kane, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eBasic Principles of Cardiovascular Pharmacology: Terminology, Pharmacokinetics, Drug-Drug Interactions, and Overdoses\u003cbr\u003eGarvan C. Kane, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eCardiovascular Physical Exam: Part 1\u003cbr\u003eKyle W. Klarich, M.D.\u003c\/li\u003e\n\u003cli\u003eCardiovascular Physical Exam: Part 2\u003cbr\u003eKyle W. Klarich, M.D.\u003c\/li\u003e\n\u003cli\u003eNew Staging System for Valve Disease\u003cbr\u003eRick A. Nishimura, M.D. and Steve R. Ommen, M.D.\u003c\/li\u003e\n\u003cli\u003eHypertension Basics\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003cli\u003eNormal Vascular Anatomy and Physiology\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003cli\u003eStatistics for the Cardiovascular Boards\u003cbr\u003eCharanjit S. Rihal, M.D.\u003c\/li\u003e\n\u003cli\u003ePolyarteritis Nodosa, Raynaud’s Phenomenon, and Kawasaki Disease\u003cbr\u003eMatthew J. Koster, M.D.\u003c\/li\u003e\n\u003cli\u003eDiabetes and the Heart\u003cbr\u003eStephen L. Kopecky, M.D.\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation and SVT: Diagnosis and Stroke Prevention\u003cbr\u003eAmmar M. Killu, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003eAtrial Fibrillation and SVT: Treatment\u003cbr\u003eMalini Madhavan, M.B.B.S.\u003c\/li\u003e\n\u003cli\u003ePacemakers, ICDs, and Cardiac Resynchronization Therapy\u003cbr\u003eRaul E. Espinosa, M.D.\u003c\/li\u003e\n\u003cli\u003eVentricular Arrhythmias\u003cbr\u003eSiva K. Mulpuru, M.D.\u003c\/li\u003e\n\u003cli\u003eCongenital Heart Disease: Part 2 – Complex\u003cbr\u003eCarole A. Warnes, M.D.\u003c\/li\u003e\n\u003cli\u003eCongenital Heart Disease: Part 1 – Simple\u003cbr\u003eCarole A. Warnes, M.D.\u003c\/li\u003e\n\u003cli\u003eACS Part II ‐ From Reperfusion to Hospital Discharge\u003cbr\u003eBrandon M. Wiley, M.D.\u003c\/li\u003e\n\u003cli\u003eAssessment and Medical Management of Paients with Known Coronary Artery Disease\u003cbr\u003ePanithaya Chareonthaitawee, M.D.\u003c\/li\u003e\n\u003cli\u003eAssessment and Primary Prevention of Patients at Risk for Cornary Artery Disease\u003cbr\u003eStephen L. Kopecky, M.D.\u003c\/li\u003e\n\u003cli\u003eComplications of Myocardial Infarction\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eRevascularization for Patients with Chronic Cornary Artery Disease\u003cbr\u003eAbhiram Prasad, M.D.\u003c\/li\u003e\n\u003cli\u003eCardiac Device and Replacement Therapy (Transplant)\u003cbr\u003eShannon M. Dunlay, M.D., M.S.\u003c\/li\u003e\n\u003cli\u003eMedical Treatment of Acute Decompensated Congestive Heart Failure\u003cbr\u003eAtta Behfar, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eMedical Treatment of Chronic Stable Congestive Heart Failure\u003cbr\u003ePaul M. McKie, M.D.\u003c\/li\u003e\n\u003cli\u003eStatistics for the Cardiovascular Boards\u003cbr\u003eCharanjit S. Rihal, M.D.\u003c\/li\u003e\n\u003cli\u003ePericardial Disease\u003cbr\u003eSteve R. Ommen, M.D.\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension\u003cbr\u003eSudhir Kushwaha, M.D.\u003c\/li\u003e\n\u003cli\u003eBasic Principles of Cardiovascular Pharmacology: Q\u0026amp;A\u003cbr\u003eGarvan C. Kane, M.D., Ph.D.\u003c\/li\u003e\n\u003cli\u003eHypertension Basics\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003cli\u003eInfective Endocarditis\u003cbr\u003eMichael W. Cullen, M.D.\u003c\/li\u003e\n\u003cli\u003eProsthetic Valves and Other Forms of Valve Disease\u003cbr\u003eJeffrey B. Geske, M.D.\u003c\/li\u003e\n\u003cli\u003eValvular Regurgitation\u003cbr\u003eRick A. Nishimura, M.D.\u003c\/li\u003e\n\u003cli\u003eCarotid and Renal Vascular Disease\u003cbr\u003eIan R. McPhail, M.D.\u003c\/li\u003e\n\u003cli\u003eDiseases of the Aorta and Great Vessels\u003cbr\u003eJuan M. Bowen, M.D.\u003c\/li\u003e\n\u003cli\u003eDiseases of the Peripheral Arteries\u003cbr\u003eAmy W. Pollak, M.D.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col s12 m12 l6 xl6\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954327195746,"sku":"MED-AMB01508","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Mayo-Clinic-Cardiovascular-Online-Board-Review-2023-VideosSlides-PDF.png?v=1779371440","url":"https:\/\/meducourse.com\/products\/mayo-clinic-cardiovascular-online-board-review-2023","provider":"Meducourse","version":"1.0","type":"link"}